General Catalyst Group Management’s Fractyl Health GUTS Stock Holding History

General Catalyst Group Management’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.88M	Hold	407,016	–	–	2.06%	7
2026 Q1	$2.24M	Hold	407,016	–	–	1.22%	7
2025 Q4	$10.7M	Hold	407,016	–	–	4.85%	6
2025 Q3	$7.77M	Hold	407,016	–	–	0.26%	8
2025 Q2	$7.91M	Buy	+407,016	New	+$7.89M	0.18%	8

Other funds holding GUTS

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

General Catalyst Group Management's GUTS Position: Q2 2026 in Review

General Catalyst Group Management held its Fractyl Health (GUTS) position steady in Q2 2026 at 407,016 shares worth $3.88M. The position accounts for 2.06% of the portfolio, ranked #7.

General Catalyst Group Management first reported a position in GUTS in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.7M in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

General Catalyst Group Management held 407,016 shares of Fractyl Health worth $3.88M as of Q2 2026.
General Catalyst Group Management left its Fractyl Health share count unchanged in Q2 2026.
Fractyl Health made up 2.06% of General Catalyst Group Management's portfolio in Q2 2026, its #7 holding.
General Catalyst Group Management first reported a position in Fractyl Health in Q2 2025 and has held it in 5 quarters since.
General Catalyst Group Management's Fractyl Health position peaked at $10.7M in Q4 2025.
77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on General Catalyst Group Management's 13F filing for Q2 2026, filed 17 Aug 2026.